Nanobiotix S.A.
NBTX | NASDAQ
$35.03
+$0.53 (+1.54%)
Sep 22, 2026, 1:40 PM ET · Market open
TTM Period Ending | Q4 2025 Dec 30, 2025 | Q2 2025 Jun 29, 2025 | Q4 2024 Dec 30, 2024 | Q2 2024 Jun 29, 2024 | Q4 2023 Dec 30, 2023 | Q2 2023 Jun 29, 2023 | Q4 2022 Dec 30, 2022 | Q2 2022 Jun 29, 2022 | Q4 2021 Dec 30, 2021 | Q2 2021 Jun 29, 2021 | Q4 2020 Dec 30, 2020 | Q2 2020 Jun 29, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -23.96M | -51.64M | -68.13M | -33.47M | -39.7M | -58.78M | -57.04M | -42.94M | -47M | -43.43M | -33.59M | -47.57M |
Depreciation & Amortization | 1.5M | 1.64M | 1.62M | 1.56M | 1.51M | 1.49M | 1.5M | 1.51M | 1.56M | 1.65M | 1.76M | 1.83M |
Stock-Based Compensation | 3.54M | 4.52M | 4.3M | 3.89M | 2.63M | 1.63M | 1.64M | 1.58M | 1.6M | 1.39M | 1.46M | 2.07M |
Other Working Capital | -5.25M | 13.45M | 13.93M | 813K | 522K | -1.21M | 1.22M | 1.74M | 14.87M | 13.08M | 1.84M | 3.98M |
Other Non-Cash Items | -11.1M | -2.9M | 28.28M | 28.21M | 11.74M | 13.23M | 17.14M | 1.01M | 9.35M | 2.98M | -2.58M | 11.65M |
Deferred Income Tax | 3K | 101K | 101K | n/a | -180K | -3.57M | -3.51M | -116K | n/a | n/a | n/a | n/a |
Change in Working Capital | -3.4M | 17.16M | 14.28M | -1.22M | 6.95M | 4.06M | 2.3M | 5.86M | 11.54M | 12.38M | 5.76M | 4.24M |
Operating Cash Flow | -33.42M | -31.13M | -19.55M | -1.04M | -12.78M | -37.72M | -38.02M | -33.46M | -31M | -30.43M | -28.24M | -33.24M |
Capital Expenditures | -546K | -509K | -848K | -494K | -329K | -338K | -93K | -262K | -233K | -83K | -107K | -714K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | -18K | -21K | -3K | n/a | -9K | -9K | 4K | -5K | 5.03M |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | 98K | 231K | 133K | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -40K | -110K | -109K | -10K | -1K | 47K | 115K | 61.5K | -7K | 2.5K | -8K | 2.46M |
Investing Cash Flow | -578K | -617K | -955K | -522K | -349K | -242K | 138K | -139K | -242K | -79K | -112K | 4.32M |
Debt Repayment | 38.19M | -6.65M | -6.2M | -2.05M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -2.31M | 1.34M | 1.07M | 48.3M | 47.07M | -3.43M | -4.74M | -4.89M | -3.09M | 52.33M | 55.88M | 1.79M |
Financial Cash Flow | 37.42M | -5.31M | -5.14M | 46.25M | 47.07M | -3.43M | -4.74M | -5.84M | -4.05M | 106.36M | 112.47M | 4.34M |
Net Cash Flow | 52.75M | 83.03M | 49.74M | 49.18M | 36.71M | -41.39M | -45.35M | -39.32M | -35.23M | 75.75M | 84.06M | -24.53M |
Free Cash Flow | -33.97M | -31.64M | -20.4M | -1.53M | -13.11M | -38.06M | -38.11M | -33.72M | -31.24M | -30.51M | -28.35M | -33.96M |
Adj. Free Cash Flow | -37.51M | -36.15M | -24.7M | -5.42M | -15.73M | -39.69M | -39.75M | -35.3M | -32.84M | -31.9M | -29.81M | -36.03M |
Maintenance CapEx | -359K | -359K | -359K | n/a | n/a | n/a | -50K | -83K | -157K | -797K | -1.55M | -1.69M |
Growth CapEx | -1.04M | -644K | -818K | -832K | -422K | -600K | -276K | -262K | -183K | n/a | n/a | n/a |
Owner Earnings | -53.33M | -32.52M | -32.69M | -38.76M | -50.8M | -71.18M | -69.07M | -63.97M | -59.4M | -64.47M | -71.31M | -68.21M |
Add to Watchlist
Select watchlists to add or remove NBTX